跳至主要内容
临床试验/NCT04328987
NCT04328987已完成不适用

Safety of Cold Snare Polypectomy in Patients With Uninterrupted Antiplatelet Agent : Aspirin vs Clopidogrel

Incheon St.Mary's Hospital1 个研究点 分布在 1 个国家目标入组 314 人开始时间: 2020年4月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
314
试验地点
1
主要终点
Delayed post polypectomy bleeding

研究概览

简要总结

Polypectomy is regarded as high risk for bleeding. Several guidelines recommend continuous use of aspirin during polypectomy. However for clopidogrel, widely used antiplatelet agent, cessation of 5-7 is recommended. There is insufficient data regarding clopidogrel on post polypectomy bleeding. Delayed bleeding after polypectomy in patients with clopidogrel was reported as 3%. A recent study showed that delayed bleeding rate in patients with clopidogrel didn't differ that of who stopped clopidogrel. However the rate for delayed bleeding was 4%, higher than the previous studies. More studies are needed to conclude the safety of polypectomy in clopidogrel users.

Cold snare polypectomy (CSP) can resect polyps without electrical energy. CSP are safe than conventional endoscopic mucosal resection in high risk for bleeding.

The polypectomy techniques in most of studies were heterogenous, where delayed bleeding was investigated in clopidogrel users. There is no study to investigate safety of CSP in patients with clopidogrel users to date. The investigators hypothesized that the bleeding risk of CSP in patients with clopidogrel users would be similar to that of aspirin users.

In this multicenter prospective study, the investigators aimed to compare the safety of CSP between aspirin and clopidogrel users.

详细描述

  • Cold snare polypectomy (CSP): resection of colorectal polyp by mechanical force of snare, without electric cautery.
  • Antiplatelet agent: single use of aspirin or clopidogrel
  • Uninterrupted (continuous) use of antiplatelet agent: cessation of antiplatelet agent less than 4 days. Cessation of antiplatelet agent is sum of before and after the CSP

ex.)

  1. patient who stopped aspirin only on the day of colonoscopy and resumed the day after colonoscopy -> cessation of aspirin was 1 day.
  2. patient who stopped aspirin only on the day of colonoscopy and resumed the 2 days after colonoscopy -> cessation of aspirin was 2 days (before colonoscopy 1day + after colonoscopy 1day).
  3. patient who stopped aspirin from 3 days before colonoscopy and resumed the day after colonoscopy -> cessation of aspirin was 4 days (-3, -2, -1, 0=on the day of colonoscopy). -> interruption of aspirin -> excluded from study.
  4. patient who stopped aspirin from 2 days before colonoscopy and resumed 2 days after colonoscopy -> cessation of aspirin was 4 days (-2, -1, 0=on the day of colonoscopy, 1=the day after colonoscopy). -> interruption of aspirin -> excluded from study.
  • BLEEDING # Immediate (intraprocedural) bleeding After CSP, bleeding will be observed for 2 minutes. Bleeding grade: (1) no bleeding, (2) minor (negligible) bleeding, (3) major bleeding, and (4) active bleeding (spurting).

In case of Grade 3 or 4, hemoclipping will be applied

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 18-80
  • polyp size <10mm
  • polyp resection : cold snare polypectomy
  • cessation of antiplatelet agent less than 4 days

排除标准

  • ASA class IV or above,
  • hematologic diseases including idiopathic thrombocytopenic purpura, leukemia, and aplastic anemia
  • advanced liver cirrhosis
  • cessation of antiplatelet agent for 4 days or more
  • dual antiplatelet agent users
  • coagulopathy (abnormal PT, aPTT, or platelet count)

结局指标

主要结局

Delayed post polypectomy bleeding

时间窗: From discharge of endoscopy unit until 4 weeks after polypectomy

Delayed bleeding will be defined when all of the following criteria were met: (1) anal bleeding after discharge of endoscopy unit and (2) identification of polypectomy bleeding site by colonoscopy.

次要结局

  • Immediate bleeding (intraprocedural bleeding)(until 2 minutes after polypectomy)

研究者

发起方
Incheon St.Mary's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tae-Geun Gweon

Assistant Professor

Incheon St.Mary's Hospital

研究点 (1)

Loading locations...

相似试验